Mode of action of Ecteinaseidin-743 (ET-743)
1999-01-01 D'Incalci, M
Complete protection by high-dose dexamethasone against the hepatotoxicity of the novel antitumor drug yondelis (ET-743) in the rat
2003-01-01 Donald, S; Verschoyle, Rd; Greaves, P; Gant, Tw; Colombo, T; Zaffaroni, M; Frapolli, R; Zucchetti, M; D'Incalci, M; Meco, D; Riccardi, R; Lopez-Lazaro, L; Jimeno, J; Gescher, Aj
Mismatch repair deficiency is associated with resistance to DNA minor groove alkylating agents
1999-01-01 Colella, G; Marchini, S; D'Incalci, M; Brown, R; Broggini, M
The novel taxane derivative, IDN6140, crosses the Blood Brain Barrier and has a promising activity in CNS tumors
2008-01-01 Marangon, E; Sala, F; Frapolli, R; Manzotti, C; Morazzoni, P; Pratesi, G; Petrangolini, G; Tortoreto, M; D'Incalci, M; Zucchetti, M
Variolin B and its derivate deoxy-variolin B: New marine natural compounds with cyclin-dependent kinase inhibitor activity
2005-01-01 Simone, M; Erba, E; Damia, G; Vikhanskaya, F; Di Francesco, Am; Riccardi, R; Bailly, C; Cuevas, C; Sousa-Faro, Jmf; D'Incalci, M
Plasma and intracellular pharmacokinetic (PK) study of prolonged infusion (PI) of gemcitabine (G) in combination with bolus cisplatin (C), in advanced nonsmall cell lung cancer.: Preliminary results
2007-01-01 Murgia, V; Caffo, O; Caldara, A; Cassetta, Mi; Fallani, S; Marangon, E; Nobili, S; Novelli, A; Zucchetti, M; D'Incalci, M; Mini, E; Galligioni, E
Cytostatic and cytotoxic effects of topotecan decoded by a novel mathematical simulation approach
2004-01-01 Lupi, M; Matera, G; Branduardi, D; D'Incalci, M; Ubezio, P
Imaging mass spectrometry: challenges in visualization of drug distribution in solid tumors
2013-01-01 Morosi, L; Zucchetti, M; D'Incalci, M; Davoli, E
HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MPA) IN ADVANCED EPITHELIAL OVARIAN-CANCER RESISTANT TO 1ST-LINE OR 2ND-LINE CHEMOTHERAPY
1981-01-01 Mangioni, C; Franceschi, S; Lavecchia, C; D'Incalci, M
ET743-induced changes in gene expression in murine cells defective in nucleotide excision repair
2001-01-01 Damia, G; Carassa, L; Marchini, S; Chiorino, G; D'Incalci, M; Faircloth, Gt; Broggini, M
Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors
2014-01-01 Soria, Jc; Debraud, F; Bahleda, R; Adamo, B; Andre, F; Dientsmann, R; Delmonte, A; Cereda, R; Isaacson, J; Litten, J; Allen, A; Dubois, F; Saba, C; Robert, R; D'Incalci, M; Zucchetti, M; Camboni, Mg; Tabernero, J
Pharmacokinetic of the novel oral camptothecin Gimatecan in patients with advanced or metastatic soft tissue sarcoma
2007-01-01 Zucchetti, M; Frapolli, R; Saracino, F; Pace, S; Barbieri, P; Mccanna, S; Grosso, F; Blay, Jy; Reichardt, P; D'Incalci, M
p21(WAF1)-derived peptides linked to an internalization peptide inhibit human cancer cell growth
1997-01-01 Bonfanti, M; Taverna, S; Salmona, M; D'Incalci, M; Broggini, M
Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models
2017-01-01 Belgiovine, C; Bello, E; Liguori, M; Craparotta, I; Mannarino, L; Paracchini, L; Beltrame, L; Marchini, S; Galmarini, Cm; Mantovani, A; Frapolli, R; Allavena, P; D'Incalci, M
CHARACTERIZATION OF A HUMAN MYXOID LIPOSARCOMA (MLS) CELL LINE MADE RESISTANT TO TRABECTEDIN (ET-743)
2010-01-01 Uboldi, S; Bernasconi, S; Marchini, S; Romano, M; Damia, G; Ganzinelli, M; Fuso, Ni; Rocchi, M; Capozzi, O; D'Incalci, M; Erba, E
PEGylated Nanoparticles Obtained through Emulsion Polymerization as Paclitaxel Carriers
2016-01-01 Colombo, C; Morosi, L; Bello, E; Ferrari, R; Licandro, Sa; Lupi, M; Ubezio, P; Morbidelli, M; Zucchetti, M; D'Incalci, M; Moscatelli, D; Frapolli, R
Synergistic combinations of brostallicin with other antitumor agents
2001-01-01 Geroni, C; Colombo, T; Marchini, S; Galliera, E; D'Incalci, M; Broggini, M
Genetic Instability Influences Drug Response in Cancer Cells
2010-01-01 Damia, G; D'Incalci, M
Daunorubicin and daunorubicinol levels in human glioma tumors after administration of liposomal encapsulated daunorubicin (Daunoxome)
1998-01-01 Zucchetti, M; Boiardi, A; Silvani, A; Parisi, I; Piccolrovazzi, S; D'Incalci, M
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis
2017-01-01 Zanotti, L; Romani, C; Tassone, L; Todeschini, P; Tassi, Ra; Bandiera, E; Damia, G; Ricci, F; Ardighieri, L; Calza, S; Marchini, S; Beltrame, L; Tognon, G; D'Incalci, M; Pecorelli, S; Sartori, E; Odicino, F; Ravaggi, A; Bignotti, E
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Mode of action of Ecteinaseidin-743 (ET-743) | 1-gen-1999 | D'Incalci, M | |
| Complete protection by high-dose dexamethasone against the hepatotoxicity of the novel antitumor drug yondelis (ET-743) in the rat | 1-gen-2003 | Donald, S; Verschoyle, Rd; Greaves, P; Gant, Tw; Colombo, T; Zaffaroni, M; Frapolli, R; Zucchetti, M; D'Incalci, M; Meco, D; Riccardi, R; Lopez-Lazaro, L; Jimeno, J; Gescher, Aj | |
| Mismatch repair deficiency is associated with resistance to DNA minor groove alkylating agents | 1-gen-1999 | Colella, G; Marchini, S; D'Incalci, M; Brown, R; Broggini, M | |
| The novel taxane derivative, IDN6140, crosses the Blood Brain Barrier and has a promising activity in CNS tumors | 1-gen-2008 | Marangon, E; Sala, F; Frapolli, R; Manzotti, C; Morazzoni, P; Pratesi, G; Petrangolini, G; Tortoreto, M; D'Incalci, M; Zucchetti, M | |
| Variolin B and its derivate deoxy-variolin B: New marine natural compounds with cyclin-dependent kinase inhibitor activity | 1-gen-2005 | Simone, M; Erba, E; Damia, G; Vikhanskaya, F; Di Francesco, Am; Riccardi, R; Bailly, C; Cuevas, C; Sousa-Faro, Jmf; D'Incalci, M | |
| Plasma and intracellular pharmacokinetic (PK) study of prolonged infusion (PI) of gemcitabine (G) in combination with bolus cisplatin (C), in advanced nonsmall cell lung cancer.: Preliminary results | 1-gen-2007 | Murgia, V; Caffo, O; Caldara, A; Cassetta, Mi; Fallani, S; Marangon, E; Nobili, S; Novelli, A; Zucchetti, M; D'Incalci, M; Mini, E; Galligioni, E | |
| Cytostatic and cytotoxic effects of topotecan decoded by a novel mathematical simulation approach | 1-gen-2004 | Lupi, M; Matera, G; Branduardi, D; D'Incalci, M; Ubezio, P | |
| Imaging mass spectrometry: challenges in visualization of drug distribution in solid tumors | 1-gen-2013 | Morosi, L; Zucchetti, M; D'Incalci, M; Davoli, E | |
| HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MPA) IN ADVANCED EPITHELIAL OVARIAN-CANCER RESISTANT TO 1ST-LINE OR 2ND-LINE CHEMOTHERAPY | 1-gen-1981 | Mangioni, C; Franceschi, S; Lavecchia, C; D'Incalci, M | |
| ET743-induced changes in gene expression in murine cells defective in nucleotide excision repair | 1-gen-2001 | Damia, G; Carassa, L; Marchini, S; Chiorino, G; D'Incalci, M; Faircloth, Gt; Broggini, M | |
| Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors | 1-gen-2014 | Soria, Jc; Debraud, F; Bahleda, R; Adamo, B; Andre, F; Dientsmann, R; Delmonte, A; Cereda, R; Isaacson, J; Litten, J; Allen, A; Dubois, F; Saba, C; Robert, R; D'Incalci, M; Zucchetti, M; Camboni, Mg; Tabernero, J | |
| Pharmacokinetic of the novel oral camptothecin Gimatecan in patients with advanced or metastatic soft tissue sarcoma | 1-gen-2007 | Zucchetti, M; Frapolli, R; Saracino, F; Pace, S; Barbieri, P; Mccanna, S; Grosso, F; Blay, Jy; Reichardt, P; D'Incalci, M | |
| p21(WAF1)-derived peptides linked to an internalization peptide inhibit human cancer cell growth | 1-gen-1997 | Bonfanti, M; Taverna, S; Salmona, M; D'Incalci, M; Broggini, M | |
| Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models | 1-gen-2017 | Belgiovine, C; Bello, E; Liguori, M; Craparotta, I; Mannarino, L; Paracchini, L; Beltrame, L; Marchini, S; Galmarini, Cm; Mantovani, A; Frapolli, R; Allavena, P; D'Incalci, M | |
| CHARACTERIZATION OF A HUMAN MYXOID LIPOSARCOMA (MLS) CELL LINE MADE RESISTANT TO TRABECTEDIN (ET-743) | 1-gen-2010 | Uboldi, S; Bernasconi, S; Marchini, S; Romano, M; Damia, G; Ganzinelli, M; Fuso, Ni; Rocchi, M; Capozzi, O; D'Incalci, M; Erba, E | |
| PEGylated Nanoparticles Obtained through Emulsion Polymerization as Paclitaxel Carriers | 1-gen-2016 | Colombo, C; Morosi, L; Bello, E; Ferrari, R; Licandro, Sa; Lupi, M; Ubezio, P; Morbidelli, M; Zucchetti, M; D'Incalci, M; Moscatelli, D; Frapolli, R | |
| Synergistic combinations of brostallicin with other antitumor agents | 1-gen-2001 | Geroni, C; Colombo, T; Marchini, S; Galliera, E; D'Incalci, M; Broggini, M | |
| Genetic Instability Influences Drug Response in Cancer Cells | 1-gen-2010 | Damia, G; D'Incalci, M | |
| Daunorubicin and daunorubicinol levels in human glioma tumors after administration of liposomal encapsulated daunorubicin (Daunoxome) | 1-gen-1998 | Zucchetti, M; Boiardi, A; Silvani, A; Parisi, I; Piccolrovazzi, S; D'Incalci, M | |
| MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis | 1-gen-2017 | Zanotti, L; Romani, C; Tassone, L; Todeschini, P; Tassi, Ra; Bandiera, E; Damia, G; Ricci, F; Ardighieri, L; Calza, S; Marchini, S; Beltrame, L; Tognon, G; D'Incalci, M; Pecorelli, S; Sartori, E; Odicino, F; Ravaggi, A; Bignotti, E |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista27918
Data di pubblicazione
- In corso di stampa14
- 2020 - 20269653
- 2010 - 201911835
- 2000 - 20094579
- 1990 - 19991485
- 1980 - 1989329
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE372
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...267
- ANNALS OF ONCOLOGY244
- CANCERS232
- PLOS ONE223
- THE JOURNAL OF NUCLEAR MEDICINE222
- JOURNAL OF CLINICAL MEDICINE215
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY197
- ALLERGY180
Keyword
- Humans2166
- Female1035
- Male996
- Middle Aged767
- Aged669
- Adult559
- COVID-19442
- Treatment Outcome373
- Animals329
- Retrospective Studies264
Lingua
- eng19972
- ita459
- spa14
- fre11
- ger8
- enm4
- por2
- chi1
Accesso al fulltext
- no fulltext25665
- reserved1362
- open891